Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Heartbeam Inc (NQ: BEAT )

2.180 -0.090 (-3.96%)
Streaming Delayed Price Updated: 9:53 AM EDT, Sep 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,110
Open 2.240
Bid (Size) 2.180 (1)
Ask (Size) 2.250 (1)
Prev. Close 2.270
Today's Range 2.180 - 2.255
52wk Range 1.580 - 6.740
Shares Outstanding 34,260,799
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Performance

YTD
-52.61%
-52.61%
1 Month
-1.35%
-1.35%
3 Month
-4.38%
-4.38%
6 Month
-8.01%
-8.01%
1 Year
+37.98%
+37.98%

More News

Read More
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Q2 2023 Financial Report, Corporate Update
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property Product Safety
HeartBeam Reports Second Quarter 2023 Financial Results
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces First Peer-Reviewed Publication Based on Its VECG Technology
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence
HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Appoints Deborah Castillo to Lead Regulatory Strategy and Execution
Via Investor Brand Network
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Host Q2 2023 Results Call, Webcast
Via Investor Brand Network
HeartBeam to Host Second Quarter 2023 Results Conference Call on Thursday August 10, 2023 at 4:30 p.m. Eastern Time
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Names Experienced Physician, Researcher to Board of Directors
Via Investor Brand Network
HeartBeam Appoints Dr. Michael R. Jaff to the Board of Directors
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Adds Wealth of Expertise to Its Board with Appointments of Ken Nelson and Mark Strome
Via Investor Brand Network
HeartBeam Appoints Ken Nelson and Mark Strome to the Board of Directors
From HeartBeam, Inc.
Via Business Wire
Strategic Alliance with Samsung and Collaboration with Dept. of Veterans Affairs to Advance Use of Unique 3-D Telehealth Technology for Heart Attack Detection and Quicker Response: BEAT
Via Get News
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung
Via Investor Brand Network
Exposures Product Safety
Monitoring Cardiac Symptoms? HeartBeam Extends Pact With Samsung For LIVMOR Solutions
Via Benzinga
InvestorNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Enters SAA with Samsung
Via Investor Brand Network
Exposures Product Safety
HeartBeam (NASDAQ: BEAT) Enters Strategic Alliance Agreement with Samsung for Cardiac Care Solutions
Via Spotlight Growth
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
HeartBeam Enters into Strategic Alliance Agreement with Samsung
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Granted Key Patent for Use in Innovative System Designed to Help Evaluate Cardiac Symptoms
Via Investor Brand Network
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
HeartBeam Announces Automated Cardiac Detection Patent Granted for HeartBeam AIMIGo™ System
From HeartBeam, Inc.
Via Business Wire
BioMedNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Announces FDA 510(k) Submission of HeartBeam AIMIGo(TM) Solution
Via Investor Brand Network
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.